Endothelium-dependent vasodilation in response to Pseudomonas aeruginosa lipopolysaccharide: an in vitro study on canine arteries.

Early systemic arterial hypotension is a common clinical feature of Pseudomonas septicemia. To determine if Pseudomonas aeruginosa endotoxin induces the release of endothelium-derived nitric oxide (EDNO), an endogenous nitrovasodilator, segments of canine femoral, renal, hepatic, superior mesenteric, and left circumflex coronary arteries were suspended in organ chambers (physiological salt solution, 95% O2/5% CO2, pH 7.4, 37 degrees C) to measure isometric force. In arterial segments contracted with 2 microM prostaglandin F2 alpha, Pseudomonas endotoxin (lipopolysaccharide (LPS) serotype 10(Habs) from Pseudomonas aeruginosa (0.05 to 0.50 mg/ml) induced concentration-dependent relaxation of segments with endothelium (P < 0.05) but no significant change in tension of arteries without endothelium. Endothelium-dependent relaxation in response to Pseudomonas LPS occurred in the presence of 1 microM indomethacin, but could be blocked in the coronary artery with 10 microM NG-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthesis from L-arginine. The inhibitory effect of L-NMMA on LPS-mediated vasorelaxation of the coronary artery could be reversed by exogenous 100 microM L-arginine but not by 100 microM D-arginine. These experiments indicate that Pseudomonas endotoxin induces synthesis of nitric oxide from L-arginine by the vascular endothelium. LPS-mediated production of EDNO by the endothelium, possibly through the action of constitutive nitric oxide synthase (NOSc), may decrease systemic vascular resistance and may be the mechanism of early hypotension characteristic of Pseudomonas septicemia.

[1]  D. Schwartz,et al.  Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. , 1997, The Journal of clinical investigation.

[2]  T. Evans,et al.  Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. , 1997, Critical care medicine.

[3]  L. Liaudet,et al.  Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia. , 1996, Clinical science.

[4]  M. Nakane,et al.  Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. , 1994, Hypertension.

[5]  I. Fleming,et al.  Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. , 1991, European journal of pharmacology.

[6]  J. Parratt,et al.  Evidence that an l‐arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin , 1991, British journal of pharmacology.

[7]  S. Moncada,et al.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Salter,et al.  Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. , 1990, Biochemical and biophysical research communications.

[9]  M. Dudley Overview of gram-negative sepsis. , 1990, American journal of hospital pharmacy.

[10]  H. Schaff,et al.  Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. , 1990, Circulation research.

[11]  C. Natanson,et al.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock , 1989, The Journal of experimental medicine.

[12]  S. Moncada,et al.  A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.

[13]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[14]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Wenzel,et al.  Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. , 1987, The Journal of infectious diseases.

[16]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[17]  L. Carey,et al.  A critical comparison of the hematologic, cardiovascular, and pulmonary response to steroids and nonsteroidal anti-inflammatory drugs in a model of sepsis and adult respiratory distress syndrome. , 1986, Surgery.

[18]  G. Cetto,et al.  Pseudomonas septicaemia. A review of 60 cases observed in a university hospital. , 1984, The Journal of hospital infection.

[19]  L. Ignarro,et al.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.

[20]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[21]  F. Glauser,et al.  Pathophysiologic alterations in endotoxemia. Similarities to an animal model. , 1980, Archives of internal medicine.

[22]  Pinghui V. Liu,et al.  Pseudomonas exotoxin shock. A preliminary report of studies in dogs. , 1968, JAMA.

[23]  D. McCormack,et al.  Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. , 1996, Journal of applied physiology.

[24]  J. Parratt Alterations in Vascular Reactivity in Sepsis and Endotoxemia , 1989 .